Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis

Rossi S, Studer V, Moscatelli A, Centonze D (2013)
PLoS ONE 8(6): e67357.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ;
Erscheinungsjahr
Zeitschriftentitel
PLoS ONE
Band
8
Zeitschriftennummer
6
Seite
e67357
ISSN
eISSN
PUB-ID

Zitieren

Rossi S, Studer V, Moscatelli A, Centonze D. Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE. 2013;8(6):e67357.
Rossi, S., Studer, V., Moscatelli, A., & Centonze, D. (2013). Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE, 8(6), e67357. doi:10.1371/journal.pone.0067357
Rossi, S., Studer, V., Moscatelli, A., and Centonze, D. (2013). Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE 8, e67357.
Rossi, S., et al., 2013. Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE, 8(6), p e67357.
S. Rossi, et al., “Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis”, PLoS ONE, vol. 8, 2013, pp. e67357.
Rossi, S., Studer, V., Moscatelli, A., Centonze, D.: Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE. 8, e67357 (2013).
Rossi, Silvia, Studer, Valeria, Moscatelli, Alessandro, and Centonze, Diego. “Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis”. PLoS ONE 8.6 (2013): e67357.

12 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
Cohen JA, Hunter SF, Brown TR, Gudesblatt M, Thrower BW, Llorens L, Souza-Prien CJ, Ruby AE, Chernoff DN, Patni R., Mult Scler (), 2018
PMID: 29368539
Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive Functions.
Musella A, Gentile A, Rizzo FR, De Vito F, Fresegna D, Bullitta S, Vanni V, Guadalupi L, Stampanoni Bassi M, Buttari F, Centonze D, Mandolesi G., Front Aging Neurosci 10(), 2018
PMID: 30135651
Heart rate variability is differentially altered in multiple sclerosis: implications for acute, worsening and progressive disability.
Studer V, Rocchi C, Motta C, Lauretti B, Perugini J, Brambilla L, Pareja-Gutierrez L, Camera G, Barbieri FR, Marfia GA, Centonze D, Rossi S., Mult Scler J Exp Transl Clin 3(2), 2017
PMID: 28607756
Intercepting virtual balls approaching under different gravity conditions: evidence for spatial prediction.
Russo M, Cesqui B, La Scaleia B, Ceccarelli F, Maselli A, Moscatelli A, Zago M, Lacquaniti F, d'Avella A., J Neurophysiol 118(4), 2017
PMID: 28768737
Influence of Genetic Variants of the N-Methyl-D-Aspartate Receptor on Emotion and Social Behavior in Adolescents.
Lee LC, Cho YC, Lin PJ, Yeh TC, Chang CY, Yeh TK., Neural Plast 2016(), 2016
PMID: 26819771
Role of amyloid-β CSF levels in cognitive deficit in MS.
Gentile A, Mori F, Bernardini S, Centonze D., Clin Chim Acta 449(), 2015
PMID: 25659291
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Ksiazek-Winiarek DJ, Szpakowski P, Glabinski A., Neural Plast 2015(), 2015
PMID: 26229689
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Ruocco G, Rossi S, Motta C, Macchiarulo G, Barbieri F, De Bardi M, Borsellino G, Finardi A, Grasso MG, Ruggieri S, Gasperini C, Furlan R, Centonze D, Battistini L, Volpe E., Clin Sci (Lond) 129(4), 2015
PMID: 25700150
Disability in multiple sclerosis: when synaptic long-term potentiation fails.
Weiss S, Mori F, Rossi S, Centonze D., Neurosci Biobehav Rev 43(), 2014
PMID: 24726576

111 References

Daten bereitgestellt von Europe PubMed Central.

Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery.
Centonze D, Rossi S, Tortiglione A, Picconi B, Prosperetti C, De Chiara V, Bernardi G, Calabresi P., Neurobiol. Dis. 27(1), 2007
PMID: 17490888
Role of NMDA receptor subtypes in different forms of NMDA-dependent synaptic plasticity.
Li R, Huang FS, Abbas AK, Wigstrom H., BMC Neurosci 8(), 2007
PMID: 17655746
D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury.
Yaka R, Biegon A, Grigoriadis N, Simeonidou C, Grigoriadis S, Alexandrovich AG, Matzner H, Schumann J, Trembovler V, Tsenter J, Shohami E., FASEB J. 21(9), 2007
PMID: 17351125
Dopamine in motor cortex is necessary for skill learning and synaptic plasticity.
Molina-Luna K, Pekanovic A, Rohrich S, Hertler B, Schubring-Giese M, Rioult-Pedotti MS, Luft AR., PLoS ONE 4(9), 2009
PMID: 19759902
Motor cortex plasticity predicts recovery in acute stroke.
Di Lazzaro V, Profice P, Pilato F, Capone F, Ranieri F, Pasqualetti P, Colosimo C, Pravata E, Cianfoni A, Dileone M., Cereb. Cortex 20(7), 2009
PMID: 19805417
Alternative excitotoxic hypotheses.
Albin RL, Greenamyre JT., Neurology 42(4), 1992
PMID: 1314341
NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo.
Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT., J. Neurosci. 27(11), 2007
PMID: 17360906
The link between excitotoxic oligodendroglial death and demyelinating diseases.
Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV., Trends Neurosci. 24(4), 2001
PMID: 11250007
Glutamate and ATP signalling in white matter pathology.
Matute C., J. Anat. 219(1), 2011
PMID: 21250988
A comparison of the pathology of primary and secondary progressive multiple sclerosis.
Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI., Brain 117 ( Pt 4)(), 1994
PMID: 7922463
Primary-progressive multiple sclerosis.
Miller DH, Leary SM., Lancet Neurol 6(10), 2007
PMID: 17884680
Multiple sclerosis.
Compston A, Coles A., Lancet 372(9648), 2008
PMID: 18970977
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptors.
Erreger K, Geballe MT, Kristensen A, Chen PE, Hansen KB, Lee CJ, Yuan H, Le P, Lyuboslavsky PN, Micale N, Jorgensen L, Clausen RP, Wyllie DJ, Snyder JP, Traynelis SF., Mol. Pharmacol. 72(4), 2007
PMID: 17622578
Mechanism of differential control of NMDA receptor activity by NR2 subunits.
Gielen M, Siegler Retchless B, Mony L, Johnson JW, Paoletti P., Nature 459(7247), 2009
PMID: 19404260
Genetic variants of the NMDA receptor influence cortical excitability and plasticity in humans.
Mori F, Ribolsi M, Kusayanagi H, Siracusano A, Mantovani V, Marasco E, Bernardi G, Centonze D., J. Neurophysiol. 106(4), 2011
PMID: 21753020
Bias reduction of maximum likelihood estimates
AUTHOR UNKNOWN, 1993
Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.
Ziemann U, Lonnecker S, Steinhoff BJ, Paulus W., Ann. Neurol. 40(3), 1996
PMID: 8797526
Clinical scales in progressive MS: predicting long-term disability.
Bosma LV, Kragt JJ, Knol DL, Polman CH, Uitdehaag BM., Mult. Scler. 18(3), 2011
PMID: 21868487
Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.
Bergamaschi R, Quaglini S, Trojano M, Amato MP, Tavazzi E, Paolicelli D, Zipoli V, Romani A, Fuiani A, Portaccio E, Berzuini C, Montomoli C, Bastianello S, Cosi V., J. Neurol. Neurosurg. Psychiatry 78(7), 2007
PMID: 17220286
MK-801 limits neurovascular dysfunction during experimental allergic encephalomyelitis.
Bolton C, Paul C., J. Pharmacol. Exp. Ther. 282(1), 1997
PMID: 9223580
The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier.
Reijerkerk A, Kooij G, van der Pol SM, Leyen T, Lakeman K, van Het Hof B, Vivien D, de Vries HE., J. Neurochem. 113(2), 2010
PMID: 20085611
Effects of NMDA receptor modulators on a blood-brain barrier in vitro model.
Neuhaus W, Freidl M, Szkokan P, Berger M, Wirth M, Winkler J, Gabor F, Pifl C, Noe CR., Brain Res. 1394(), 2011
PMID: 21549356
Optical coherence tomography in multiple sclerosis.
Frohman E, Costello F, Zivadinov R, Stuve O, Conger A, Winslow H, Trip A, Frohman T, Balcer L., Lancet Neurol 5(10), 2006
PMID: 16987732
Optical coherence tomography: a window into the mechanisms of multiple sclerosis.
Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ., Nat Clin Pract Neurol 4(12), 2008
PMID: 19043423
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.
Barkhof F, Calabresi PA, Miller DH, Reingold SC., Nat Rev Neurol 5(5), 2009
PMID: 19488083
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
Burkholder BM, Osborne B, Loguidice MJ, Bisker E, Frohman TC, Conger A, Ratchford JN, Warner C, Markowitz CE, Jacobs DA, Galetta SL, Cutter GR, Maguire MG, Calabresi PA, Balcer LJ, Frohman EM., Arch. Neurol. 66(11), 2009
PMID: 19901168
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.
Baier ML, Cutter GR, Rudick RA, Miller D, Cohen JA, Weinstock-Guttman B, Mass M, Balcer LJ., Neurology 64(6), 2005
PMID: 15781814
Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ., Nat. Med. 14(8), 2008
PMID: 18568035
Cognitive and cortical plasticity deficits correlate with altered amyloid-β CSF levels in multiple sclerosis.
Mori F, Rossi S, Sancesario G, Codeca C, Mataluni G, Monteleone F, Buttari F, Kusayanagi H, Castelli M, Motta C, Studer V, Bernardi G, Koch G, Bernardini S, Centonze D., Neuropsychopharmacology 36(3), 2010
PMID: 20944553
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP, Portaccio E, Goretti B, Zipoli V, Battaglini M, Bartolozzi ML, Stromillo ML, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N., Arch. Neurol. 64(8), 2007
PMID: 17698706
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M., Arch. Neurol. 66(9), 2009
PMID: 19752305
Glutamate inhibition in MS: the neuroprotective properties of riluzole.
Killestein J, Kalkers NF, Polman CH., J. Neurol. Sci. 233(1-2), 2005
PMID: 15949499
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T. Brain
AUTHOR UNKNOWN, 2005
Glutamate receptor expression in multiple sclerosis lesions.
Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, Smith T., Brain Pathol. 18(1), 2007
PMID: 17924980
Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.
Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D., Brain 133(9), 2010
PMID: 20802204
Increased expression of cystine/glutamate antiporter in multiple sclerosis.
Pampliega O, Domercq M, Soria FN, Villoslada P, Rodriguez-Antiguedad A, Matute C., J Neuroinflammation 8(), 2011
PMID: 21639880
The plasticity-pathology continuum: defining a role for the LTP phenomenon.
McEachern JC, Shaw CA., J. Neurosci. Res. 58(1), 1999
PMID: 10491571
Synaptic plasticity in the ischaemic brain.
Calabresi P, Centonze D, Pisani A, Cupini L, Bernardi G., Lancet Neurol 2(10), 2003
PMID: 14505584
Widespread up-regulation of N-methyl-D-aspartate receptors after focal photothrombotic lesion in rat brain.
Que M, Schiene K, Witte OW, Zilles K., Neurosci. Lett. 273(2), 1999
PMID: 10505620
Plasticity and repair in the post-ischemic brain.
Di Filippo M, Tozzi A, Costa C, Belcastro V, Tantucci M, Picconi B, Calabresi P., Neuropharmacology 55(3), 2008
PMID: 18359495
NR2B subunit exerts a critical role in postischemic synaptic plasticity.
Picconi B, Tortiglione A, Barone I, Centonze D, Gardoni F, Gubellini P, Bonsi P, Pisani A, Bernardi G, Di Luca M, Calabresi P., Stroke 37(7), 2006
PMID: 16741178
A possible association of responsiveness to adrenocorticotropic hormone with specific GRIN1 haplotypes in infantile spasms.
Ding YX, Zhang Y, He B, Yue WH, Zhang D, Zou LP., Dev Med Child Neurol 52(11), 2010
PMID: 20722663
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
Endele S, Rosenberger G, Geider K, Popp B, Tamer C, Stefanova I, Milh M, Kortum F, Fritsch A, Pientka FK, Hellenbroich Y, Kalscheuer VM, Kohlhase J, Moog U, Rappold G, Rauch A, Ropers HH, von Spiczak S, Tonnies H, Villeneuve N, Villard L, Zabel B, Zenker M, Laube B, Reis A, Wieczorek D, Van Maldergem L, Kutsche K., Nat. Genet. 42(11), 2010
PMID: 20890276
Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease in Chinese Han population in Shanghai.
Chen C, Li X, Wang T, Wang HH, Fu Y, Zhang L, Xiao SF., Neurosci Bull 26(5), 2010
PMID: 20882066
Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson's disease in a hospital-based case-control study.
Wu SL, Wang WF, Shyu HY, Ho YJ, Shieh JC, Fu YP, Wu ST, Cheng CW., Neurosci. Lett. 478(2), 2010
PMID: 20438806
Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population.
Galehdari H, Pooryasin A, Foroughmand A, Daneshmand S, Saadat M., J. Mol. Neurosci. 38(2), 2008
PMID: 18792810

AUTHOR UNKNOWN, 0
Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder.
Dorval KM, Wigg KG, Crosbie J, Tannock R, Kennedy JL, Ickowicz A, Pathare T, Malone M, Schachar R, Barr CL., Genes Brain Behav. 6(5), 2006
PMID: 17010153
Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder.
Mundo E, Tharmalingham S, Neves-Pereira M, Dalton EJ, Macciardi F, Parikh SV, Bolonna A, Kerwin RW, Arranz MJ, Makoff AJ, Kennedy JL., Mol. Psychiatry 8(2), 2003
PMID: 12610658
Memories of NMDA receptors and LTP.
Collingridge GL, Bliss TV., Trends Neurosci. 18(2), 1995
PMID: 7537406
Expression mechanisms underlying NMDA receptor-dependent long-term potentiation.
Nicoll RA, Malenka RC., Ann. N. Y. Acad. Sci. 868(), 1999
PMID: 10414328
Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease.
Milnerwood AJ, Raymond LA., Trends Neurosci. 33(11), 2010
PMID: 20850189
Calcium-dependent mitochondrial function and dysfunction in neurons.
Pivovarova NB, Andrews SB., FEBS J. 277(18), 2010
PMID: 20659161
Increased levels of d-aspartate in the hippocampus enhance LTP but do not facilitate cognitive flexibility.
Errico F, Nistico R, Palma G, Federici M, Affuso A, Brilli E, Topo E, Centonze D, Bernardi G, Bozzi Y, D'Aniello A, Di Lauro R, Mercuri NB, Usiello A., Mol. Cell. Neurosci. 37(2), 2007
PMID: 17981050
Increased D-aspartate brain content rescues hippocampal age-related synaptic plasticity deterioration of mice.
Errico F, Nistico R, Napolitano F, Mazzola C, Astone D, Pisapia T, Giustizieri M, D'Aniello A, Mercuri NB, Usiello A., Neurobiol. Aging 32(12), 2010
PMID: 20097447
Persistent increase of D-aspartate in D-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay.
Errico F, Nistico R, Napolitano F, Oliva AB, Romano R, Barbieri F, Florio T, Russo C, Mercuri NB, Usiello A., Neurobiol. Aging 32(11), 2009
PMID: 20031274
Memantine induces reversible neurologic impairment in patients with MS.
Villoslada P, Arrondo G, Sepulcre J, Alegre M, Artieda J., Neurology 72(19), 2008
PMID: 19092106
Glutamate-induced alterations in Ca2+ signaling are modulated by mitochondrial Ca2+ handling capacity in brain slices of R6/1 transgenic mice.
Rosenstock TR, Bertoncini CR, Teles AV, Hirata H, Fernandes MJ, Smaili SS., Eur. J. Neurosci. 32(1), 2010
PMID: 20608968
Differential NMDA receptor-dependent calcium loading and mitochondrial dysfunction in CA1 vs. CA3 hippocampal neurons.
Stanika RI, Winters CA, Pivovarova NB, Andrews SB., Neurobiol. Dis. 37(2), 2009
PMID: 19879359
A possible pivotal role of mitochondrial free calcium in neurotoxicity mediated by N-methyl-d-aspartate receptors in cultured rat hippocampal neurons.
Kambe Y, Nakamichi N, Takarada T, Fukumori R, Nakazato R, Hinoi E, Yoneda Y., Neurochem. Int. 59(1), 2011
PMID: 21669242
The involvement of mitochondria in the pathogenesis of multiple sclerosis.
Kalman B, Laitinen K, Komoly S., J. Neuroimmunol. 188(1-2), 2007
PMID: 17493689
Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?
Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J., Mitochondrion 10(5), 2010
PMID: 20573557
Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.
Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O, Lassmann H, Turnbull DM, Mahad DJ., Ann. Neurol. 69(3), 2010
PMID: 21446022
Interference of short-interval intracortical inhibition (SICI) and short-interval intracortical facilitation (SICF).
Peurala SH, Muller-Dahlhaus JF, Arai N, Ziemann U., Clin Neurophysiol 119(10), 2008
PMID: 18723394
Dextromethorphan decreases the excitability of the human motor cortex.
Ziemann U, Chen R, Cohen LG, Hallett M., Neurology 51(5), 1998
PMID: 9818853
Influence of the N-methyl-D-aspartate antagonist memantine on human motor cortex excitability.
Schwenkreis P, Witscher K, Janssen F, Addo A, Dertwinkel R, Zenz M, Malin JP, Tegenthoff M., Neurosci. Lett. 270(3), 1999
PMID: 10462113
Riluzole suppresses motor cortex facilitation in correlation to its plasma level. A study using transcranial magnetic stimulation.
Schwenkreis P, Liepert J, Witscher K, Fischer W, Weiller C, Malin JP, Tegenthoff M., Exp Brain Res 135(3), 2000
PMID: 11146807
Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.
Rodriguez MC, Obeso JA, Olanow CW., Ann. Neurol. 44(3 Suppl 1), 1998
PMID: 9749591
Glutamatergic influences on the basal ganglia.
Greenamyre JT., Clin Neuropharmacol 24(2), 2001
PMID: 11307040
Possible association between genetic variants at the GRIN1 gene and schizophrenia with lifetime history of depressive symptoms in a German sample.
Georgi A, Jamra RA, Klein K, Villela AW, Schumacher J, Becker T, Paul T, Schmael C, Hofels S, Klopp N, Illig T, Propping P, Cichon S, Nothen MM, Schulze TG, Rietschel M., Psychiatr. Genet. 17(5), 2007
PMID: 17728671
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.
Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, Gur RC, Siegel SJ., Genes Brain Behav. 8(7), 2009
PMID: 19563516
The concept of long term potentiation of transmission at synapses.
Bennett MR., Prog. Neurobiol. 60(2), 2000
PMID: 10639051
Long-term potentiation and cognitive drug discovery.
Cooke SF, Bliss TV., Curr Opin Investig Drugs 6(1), 2005
PMID: 15675601
Plasticity in the human central nervous system.
Cooke SF, Bliss TV., Brain 129(Pt 7), 2006
PMID: 16672292
Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation.
Miglio G, Varsaldi F, Lombardi G., Biochem. Biophys. Res. Commun. 338(4), 2005
PMID: 16289038
Astrocytes of the mouse neocortex express functional N-methyl-D-aspartate receptors.
Schipke CG, Ohlemeyer C, Matyash M, Nolte C, Kettenmann H, Kirchhoff F., FASEB J. 15(7), 2001
PMID: 11344110
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Grasselli G, Rossi S, Musella A, Gentile A, Loizzo S, Muzio L, Di Sanza C, Errico F, Musumeci G, Haji N, Fresegna D, Sepman H, De Chiara V, Furlan R, Martino G, Usiello A, Mandolesi G, Centonze D., Br. J. Pharmacol. 168(2), 2013
PMID: 22924679
NMDA receptors are expressed in oligodendrocytes and activated in ischaemia.
Karadottir R, Cavelier P, Bergersen LH, Attwell D., Nature 438(7071), 2005
PMID: 16372011
NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia.
Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, Yin X, Trapp BD, McRory JE, Rehak R, Zamponi GW, Wang W, Stys PK., Nature 439(7079), 2005
PMID: 16372019
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.
Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA., Neurology 69(16), 2007
PMID: 17938370
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis.
Grazioli E, Zivadinov R, Weinstock-Guttman B, Lincoff N, Baier M, Wong JR, Hussein S, Cox JL, Hojnacki D, Ramanathan M., J. Neurol. Sci. 268(1-2), 2007
PMID: 18054962
Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes.
Costello F, Hodge W, Pan YI, Freedman M, DeMeulemeester C., J. Neurol. Sci. 281(1-2), 2009
PMID: 19303605
Molecular basis of glutamate toxicity in retinal ganglion cells.
Sucher NJ, Lipton SA, Dreyer EB., Vision Res. 37(24), 1997
PMID: 9425525
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".
Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS., Ann. Neurol. 58(6), 2005
PMID: 16283615
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
Roxburgh RH, Seaman SR, Masterman T, Hensiek AE, Sawcer SJ, Vukusic S, Achiti I, Confavreux C, Coustans M, le Page E, Edan G, McDonnell GV, Hawkins S, Trojano M, Liguori M, Cocco E, Marrosu MG, Tesser F, Leone MA, Weber A, Zipp F, Miterski B, Epplen JT, Oturai A, Sorensen PS, Celius EG, Lara NT, Montalban X, Villoslada P, Silva AM, Marta M, Leite I, Dubois B, Rubio J, Butzkueven H, Kilpatrick T, Mycko MP, Selmaj KW, Rio ME, Sa M, Salemi G, Savettieri G, Hillert J, Compston DA., Neurology 64(7), 2005
PMID: 15824338
Development of a multiple sclerosis functional composite as a clinical trial outcome measure.
Cutter GR, Baier ML, Rudick RA, Cookfair DL, Fischer JS, Petkau J, Syndulko K, Weinshenker BG, Antel JP, Confavreux C, Ellison GW, Lublin F, Miller AE, Rao SM, Reingold S, Thompson A, Willoughby E., Brain 122 ( Pt 5)(), 1999
PMID: 10355672

AUTHOR UNKNOWN, 0
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment.
Amato MP, Bartolozzi ML, Zipoli V, Portaccio E, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, De Stefano N., Neurology 63(1), 2004
PMID: 15249616
The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population.
Amato MP, Portaccio E, Goretti B, Zipoli V, Ricchiuti L, De Caro MF, Patti F, Vecchio R, Sorbi S, Trojano M., Mult. Scler. 12(6), 2006
PMID: 17263008
A normative study on visual reaction times and two Stroop colour-word tests.
Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E., Ital J Neurol Sci 19(3), 1998
PMID: 10933471
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.
Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW., Brain 122 ( Pt 7)(), 1999
PMID: 10388799
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G; COGIMUS Study Group, Patti F, Lo Fermo S, Vecchio R, Maimone D, Messina S, Gasperini C, Orefice V, Brescia Morra V, Florio C, Amato MP, Goretti B, Portaccio E, Zipoli V, Bertolotto A, Bramanti P, Sessa E, Centonze D, Cottone S, Salemi G, Falcini M, Gallo P, Perini P, Gigli GL, Giuliani G, Grimaldi LM, Murri L, Lugaresi A, Monaco F, Montanari E, Motti L, Neri S, Paciello M, Provinciali L, Ragno M, Rosati G, Ruggieri S, Tola MR, Caniatti L, Tonali P, Batocchi AP, Trojano M, Di Monte E, De Caro MF, Ghezzi A, Zaffaroni M, Zolo P, Zorzon M, Signorino M, Scarpini E, Durelli L, Carolei A, Todaro M, Spitaleri D, Tartaglione A., Mult. Scler. 15(7), 2009
PMID: 19542262
Cognitive impairment in multiple sclerosis.
Patti F., Mult. Scler. 15(1), 2008
PMID: 18805842
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.
Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, Furlan R, Centonze D., Mult. Scler. 17(11), 2011
PMID: 21677024
Corticocortical inhibition in human motor cortex.
Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD., J. Physiol. (Lond.) 471(), 1993
PMID: 8120818
Automated genotyping using the DNA MassArray technology.
Jurinke C, van den Boom D, Cantor CR, Koster H., Methods Mol. Biol. 187(), 2002
PMID: 12013745
A simple sequentially rejective multiple test procedure
AUTHOR UNKNOWN, 1979
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM, Larson RA, Allan JM, Onel K., Blood 112(3), 2008
PMID: 18426989

AUTHOR UNKNOWN, 0
Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis.
Sombekke MH, Arteta D, van de Wiel MA, Crusius JB, Tejedor D, Killestein J, Martinez A, Pena AS, Polman CH, Uitdehaag BM., Mult. Scler. 16(6), 2010
PMID: 20378664

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 23840674
PubMed | Europe PMC

Suchen in

Google Scholar